Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-04-13

Clinical Trial Update: Efficacy Evaluation of Intravenous Brivaracetam and Phenytoin in Subjects With Nonconvulsive Electrographic Seizures [Phase 2]

View source ↗

Summary

A Phase 2 trial update comparing intravenous brivaracetam and phenytoin for nonconvulsive electrographic seizures; the study was terminated with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BRIVARACETAM (brivaracetam)
  • Phenytoin (Phenytoin)

Snippet

Sponsor: UCB BIOSCIENCES, Inc. | Conditions: Nonconvulsive Electrographic Seizures | Phase 2 | Status: TERMINATED | Results posted: 2016-04-13